196 related articles for article (PubMed ID: 13130334)
1. [Cost of general medical care of patients suffering from chronic inflammatory bowel disease].
Bokemeyer B
Z Gastroenterol; 2003 Sep; 41(9):963-4. PubMed ID: 13130334
[No Abstract] [Full Text] [Related]
2. [Costs of ambulant care for patients with inflammatory bowel disease in general practice].
Beiche A; König HH; Ebinger M; Matysiak-Klose D; Braun V; Leidl R
Z Gastroenterol; 2003 Jun; 41(6):527-36. PubMed ID: 12806538
[TBL] [Abstract][Full Text] [Related]
3. [Cost measurement based on a cost diary in patients with inflammatory bowel disease].
Rösch M; Leidl R; Tirpitz Cv; Reinshagen M; Adler G; König HH
Z Gastroenterol; 2002 Apr; 40(4):217-28. PubMed ID: 11961730
[TBL] [Abstract][Full Text] [Related]
4. [Recurrence-preventive (remission preserving) therapy of chronic inflammatory bowel diseases].
Kruis W; Pohl C
Dtsch Med Wochenschr; 1998 Jan; 123(4):85-7. PubMed ID: 9487288
[No Abstract] [Full Text] [Related]
5. Medical management of inflammatory bowel disease in the new millennium.
Lombardi DA; Feller ER; Shah SA
Compr Ther; 2002; 28(1):39-49. PubMed ID: 11894442
[TBL] [Abstract][Full Text] [Related]
6. Medical management of specific clinical presentations.
Bitton A; Peppercorn MA
Gastroenterol Clin North Am; 1995 Sep; 24(3):541-58. PubMed ID: 8809235
[TBL] [Abstract][Full Text] [Related]
7. [Measurement of outpatient treatment costs of chronic inflammatory bowel diseases at a German university hospital].
Rösch M; Leidl R; Thomas S; von Tirpitz C; Reinshagen M; Adler G; König HH
Med Klin (Munich); 2002 Mar; 97(3):128-36. PubMed ID: 11957787
[TBL] [Abstract][Full Text] [Related]
8. Refractory inflammatory bowel disease in children.
Oliva-Hemker M; Escher JC; Moore D; Dubinksy M; Hildebrand H; Koda YK; Murch S; Sandhu B; Seo JK; Tanzi MN; Warner B;
J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):266-72. PubMed ID: 18664886
[No Abstract] [Full Text] [Related]
9. Rate of Adverse Events and Associated Health Care Costs for the Management of Inflammatory Bowel Disease in Germany.
Wilke T; Groth A; Long GH; Tatro AR; Sun D
Clin Ther; 2020 Jan; 42(1):130-143.e3. PubMed ID: 31883702
[TBL] [Abstract][Full Text] [Related]
10. Analyzing hospital costs for patients with inflammatory bowel disease.
Picco MF; Bayless TM
Am J Gastroenterol; 2000 Mar; 95(3):577-8. PubMed ID: 10710040
[No Abstract] [Full Text] [Related]
11. [Chronic inflammatory bowel diseases. Update on evidence-based therapy].
MMW Fortschr Med; 2005 Apr; 147(17):58-9. PubMed ID: 15903063
[No Abstract] [Full Text] [Related]
12. Cost of outpatient care in patients with inflammatory bowel disease in a German University Hospital.
Ebinger M; Leidl R; Thomas S; Von Tirpitz C; Reinshagen M; Adler G; Konig HH
J Gastroenterol Hepatol; 2004 Feb; 19(2):192-9. PubMed ID: 14731130
[TBL] [Abstract][Full Text] [Related]
13. Predicting the need for azathioprine at first presentation in children with inflammatory bowel disease.
Mossop H; Davies P; Murphy MS
J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):123-9. PubMed ID: 18664861
[TBL] [Abstract][Full Text] [Related]
14. [Follow up of the use of biological drugs against inflammatory bowel diseases].
Moum B
Tidsskr Nor Laegeforen; 2007 Nov; 127(21):2841-2. PubMed ID: 17987080
[No Abstract] [Full Text] [Related]
15. Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation.
Odes S; Vardi H; Friger M; Wolters F; Russel MG; Riis L; Munkholm P; Politi P; Tsianos E; Clofent J; Vermeire S; Monteiro E; Mouzas I; Fornaciari G; Sijbrandij J; Limonard C; Van Zeijl G; O'morain C; Moum B; Vatn M; Stockbrugger R;
Gastroenterology; 2006 Sep; 131(3):719-28. PubMed ID: 16952541
[TBL] [Abstract][Full Text] [Related]
16. [Therapy of chronic inflammatory bowel diseases. Long-term ambulatory care].
Rohr G
Verh Dtsch Ges Inn Med; 1988; 94():212-5. PubMed ID: 3144811
[No Abstract] [Full Text] [Related]
17. [Cyclosporine A and chronic inflammatory diseases of the digestive tract].
Brazier F; Finet L; Duchmann JC; Dupas JL
Gastroenterol Clin Biol; 1995 May; 19(5):494-504. PubMed ID: 7590001
[No Abstract] [Full Text] [Related]
18. [Chronic inflammatory bowel diseases. Immunosuppressive drugs--good alternatives to steroids].
MMW Fortschr Med; 2001 Jul; 143(26-27):54-6. PubMed ID: 11481920
[No Abstract] [Full Text] [Related]
19. Cost-effectiveness of thiopurine methyltransferase genotype screening in patients about to commence azathioprine therapy for treatment of inflammatory bowel disease.
Winter J; Walker A; Shapiro D; Gaffney D; Spooner RJ; Mills PR
Aliment Pharmacol Ther; 2004 Sep; 20(6):593-9. PubMed ID: 15352906
[TBL] [Abstract][Full Text] [Related]
20. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
